Lab News
Technology gives labs a hand with utilization management
September 16, 2019 -- Lab testing is notoriously prone to errors of overuse and underuse, with serious financial and clinical consequences. When word of mouth isn't enough to change course, machine-learning models and computerized systems for monitoring the use of tests can step in with objective support, new studies show.
Discuss
September 16, 2019 -- Lab testing is notoriously prone to errors of overuse and underuse, with serious financial and clinical consequences. When word of mouth isn't enough to change course, machine-learning models and computerized systems for monitoring the use of tests can step in with objective support, new studies show.
Discuss Do all metastatic breast cancer patients deserve genetic testing?
September 13, 2019 -- National Comprehensive Cancer Network guidelines should be changed to advise genetic testing for all patients with metastatic breast cancer, according to a recent study in JAMA Oncology. Profiling is needed so that patients won't miss out on targeted clinical trials and drug therapies, the researchers explained.
Discuss
September 13, 2019 -- National Comprehensive Cancer Network guidelines should be changed to advise genetic testing for all patients with metastatic breast cancer, according to a recent study in JAMA Oncology. Profiling is needed so that patients won't miss out on targeted clinical trials and drug therapies, the researchers explained.
Discuss T2 Biosystems advances new tests through BARDA funding
September 12, 2019 -- T2 Biosystems is accelerating the development of new direct-from-blood tests through a milestone-based funding contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) worth $6 million initially and up to a total of $69 million if deal options are exercised.
Discuss
September 12, 2019 -- T2 Biosystems is accelerating the development of new direct-from-blood tests through a milestone-based funding contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) worth $6 million initially and up to a total of $69 million if deal options are exercised.
Discuss Point-of-care testing tackles diabetes risk in Texas
September 12, 2019 -- One of the key advantages of point-of-care (POC) testing is the ability to offer test results within a matter of minutes, instead of several hours or a few days with central lab testing. Health officials in Texas were able to leverage POC technology to boost participation in a program designed to tackle one county's growing diabetes epidemic.
Discuss
September 12, 2019 -- One of the key advantages of point-of-care (POC) testing is the ability to offer test results within a matter of minutes, instead of several hours or a few days with central lab testing. Health officials in Texas were able to leverage POC technology to boost participation in a program designed to tackle one county's growing diabetes epidemic.
Discuss Blood test helps gauge lung cancer risk in heavy smokers
September 11, 2019 -- Pairing a microRNA blood test with low-dose computed tomography scans helps assess risk for lung cancer and guide screening efforts, according to an Italian study of heavy smokers presented during a presidential symposium on September 9 at the World Conference on Lung Cancer in Barcelona, Spain.
Discuss
September 11, 2019 -- Pairing a microRNA blood test with low-dose computed tomography scans helps assess risk for lung cancer and guide screening efforts, according to an Italian study of heavy smokers presented during a presidential symposium on September 9 at the World Conference on Lung Cancer in Barcelona, Spain.
Discuss Personal Genome Diagnostics touts liquid biopsy data
September 10, 2019 -- Personal Genome Diagnostics reported positive study results for a 58-gene panel liquid biopsy test for assessing microsatellite instability and tumor mutational burden in an article published online September 10 in Clinical Cancer Research.
Discuss
September 10, 2019 -- Personal Genome Diagnostics reported positive study results for a 58-gene panel liquid biopsy test for assessing microsatellite instability and tumor mutational burden in an article published online September 10 in Clinical Cancer Research.
Discuss ASCP tackles hepatitis C, stool pathogens, and more in new test guidelines
September 10, 2019 -- The American Society for Clinical Pathology (ASCP) has released five new recommendations for appropriate lab test ordering, including advice against repeat hepatitis C virus testing and testing for community-acquired gastrointestinal pathogens in stool in hospitalized patients.
Discuss
September 10, 2019 -- The American Society for Clinical Pathology (ASCP) has released five new recommendations for appropriate lab test ordering, including advice against repeat hepatitis C virus testing and testing for community-acquired gastrointestinal pathogens in stool in hospitalized patients.
Discuss Blood biomarkers improve early detection of lung cancer
September 9, 2019 -- The combination of a lung cancer biomarker blood test and imaging-based screening helped improve the early detection of lung cancer in an ongoing national trial in Scotland. The findings were presented at a September 9 presidential symposium during the World Conference on Lung Cancer in Barcelona, Spain.
Discuss
September 9, 2019 -- The combination of a lung cancer biomarker blood test and imaging-based screening helped improve the early detection of lung cancer in an ongoing national trial in Scotland. The findings were presented at a September 9 presidential symposium during the World Conference on Lung Cancer in Barcelona, Spain.
Discuss CAP offers guideline on molecular testing in brain cancer
September 9, 2019 -- The College of American Pathologists (CAP) on September 9 released new draft recommendations on biomarkers for diffuse gliomas, the most common group of primary brain tumors. The move recognizes the growing importance of molecular testing in tumor classification.
Discuss
September 9, 2019 -- The College of American Pathologists (CAP) on September 9 released new draft recommendations on biomarkers for diffuse gliomas, the most common group of primary brain tumors. The move recognizes the growing importance of molecular testing in tumor classification.
Discuss Genotyping spares bleeding with cardiovascular drugs
September 5, 2019 -- Genotype-guided treatment meant less bleeding for some patients who underwent primary percutaneous coronary intervention and were taking blood thinners in a Dutch study presented at the European Society of Cardiology and World Congress of Cardiology joint meeting, held August 31 to September 4 in Paris.
Discuss
September 5, 2019 -- Genotype-guided treatment meant less bleeding for some patients who underwent primary percutaneous coronary intervention and were taking blood thinners in a Dutch study presented at the European Society of Cardiology and World Congress of Cardiology joint meeting, held August 31 to September 4 in Paris.
Discuss
News in Brief
Conferences
Association for Molecular Pathology (AMP) Molecular Pathology Economics Summit
September 20
Washington, DC, District of Columbia United States
September 20
Washington, DC, District of Columbia United States
College of American Pathologists (CAP) Annual Meeting
September 21-25
Orlando, Florida United States
September 21-25
Orlando, Florida United States
MedTech Conference
September 23-25
Boston, Massachusetts United States
September 23-25
Boston, Massachusetts United States
Traps and Pitfalls to Avoid in Urologic Pathology
September 24-26
Palm Springs, California United States
September 24-26
Palm Springs, California United States
Brazilian Congress of Clinical Pathology/Laboratory Medicine
September 24-27
Rio de Janeiro, Rio de Janeiro Brazil
September 24-27
Rio de Janeiro, Rio de Janeiro Brazil
Connect
Latest Tweets